| Year |
Citation |
Score |
| 2016 |
Griebel G, Pichat P, Boulay D, Naimoli V, Potestio L, Featherstone R, Sahni S, Defex H, Desvignes C, Slowinski F, Vigé X, Bergis OE, Sher R, Kosley R, Kongsamut S, ... Black MD, et al. The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia. Scientific Reports. 6: 35320. PMID 27734956 DOI: 10.1038/Srep35320 |
0.566 |
|
| 2015 |
Naimoli V, Featherstone R, Potestio L, Kosley R, Varty G, Griebel G, Black M. Compound A, a novel, potent and selective mGluR2 positive allosteric modulator: III. Effects in clinically relevant translational cognition models that could be used as biomarkers F1000research. 4. DOI: 10.7490/F1000Research.1110033.1 |
0.552 |
|
| 2012 |
Griebel G, Pichat P, Pruniaux MP, Beeské S, Lopez-Grancha M, Genet E, Terranova JP, Castro A, Sánchez JA, Black M, Varty GB, Weiner I, Arad M, Barak S, De Levie A, et al. SAR110894, a potent histamine H₃-receptor antagonist, displays procognitive effects in rodents. Pharmacology, Biochemistry, and Behavior. 102: 203-14. PMID 22542742 DOI: 10.1016/J.Pbb.2012.04.004 |
0.397 |
|
| 2011 |
Black MD, Stevens RJ, Rogacki N, Featherstone RE, Senyah Y, Giardino O, Borowsky B, Stemmelin J, Cohen C, Pichat P, Arad M, Barak S, De Levie A, Weiner I, Griebel G, et al. AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents. Psychopharmacology. 215: 149-63. PMID 21181124 DOI: 10.1007/S00213-010-2124-0 |
0.502 |
|
| 2011 |
Liang G, Neuenschwander K, Chen X, Wei L, Munson R, Francisco G, Scotese A, Shutske G, Black M, Sarhan S, Jiang J, Morize I, Vaz RJ. Structure-based design, synthesis, and profiling of potent and selective neuronal nitric oxide synthase (nNOS) inhibitors with an amidinothiophene hydroxypiperidine scaffold Medchemcomm. 2: 201-205. DOI: 10.1039/C0Md00255K |
0.303 |
|
| 2009 |
Barak S, Arad M, De Levie A, Black MD, Griebel G, Weiner I. Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1753-63. PMID 19158670 DOI: 10.1038/Npp.2008.232 |
0.498 |
|
| 2009 |
Black MD, Varty GB, Arad M, Barak S, De Levie A, Boulay D, Pichat P, Griebel G, Weiner I. Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat. Psychopharmacology. 202: 385-96. PMID 18709358 DOI: 10.1007/S00213-008-1289-2 |
0.464 |
|
| 2005 |
Black MD. Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data. Psychopharmacology. 179: 154-63. PMID 15672275 DOI: 10.1007/S00213-004-2065-6 |
0.395 |
|
| 2002 |
Black MD, Simmonds J, Senyah Y, Wettstein JG. Neonatal nitric oxide synthase inhibition: social interaction deficits in adulthood and reversal by antipsychotic drugs. Neuropharmacology. 42: 414-20. PMID 11897119 DOI: 10.1016/S0028-3908(01)00180-0 |
0.352 |
|
| 2000 |
Black MD, Wotanis J, Schilp DE, Hanak SE, Sorensen SM, Wettstein JG. Effect of AMPA receptor modulators on hippocampal and cortical function. European Journal of Pharmacology. 394: 85-90. PMID 10771038 DOI: 10.1016/S0014-2999(00)00120-5 |
0.342 |
|
| 1999 |
Black MD, Selk DE, Hitchcock JM, Wettstein JG, Sorensen SM. On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia. Neuropharmacology. 38: 1299-306. PMID 10471083 DOI: 10.1016/S0028-3908(99)00041-6 |
0.354 |
|
| 1999 |
Schilp DE, Sorensen SM, Wettstein JG, Black MD. Effects of glycine antagonists in an acute in vitro electrophysiological model of ischemia Drug Development Research. 46: 134-138. DOI: 10.1002/(Sici)1098-2299(199902)46:2<134::Aid-Ddr6>3.0.Co;2-9 |
0.369 |
|
| 1992 |
Black MD, Carey F, Crossman AR, Relton JK, Rothwell NJ. Lipocortin-1 inhibits NMDA receptor-mediated neuronal damage in the striatum of the rat. Brain Research. 585: 135-40. PMID 1387336 DOI: 10.1016/0006-8993(92)91198-N |
0.33 |
|
| Show low-probability matches. |